Published in Biochemistry on August 23, 1977
The catalytic Mn2+ sites in the enolase-inhibitor complex: crystallography, single-crystal EPR, and DFT calculations. J Am Chem Soc (2007) 0.83
Gamma-enolase: a well-known tumour marker, with a less-known role in cancer. Radiol Oncol (2015) 0.77
Biochemical and Structural Characterization of Enolase from Chloroflexus aurantiacus: Evidence for a Thermophilic Origin. Front Bioeng Biotechnol (2015) 0.75
Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet (2001) 9.75
Prevalence of antibodies to human immunodeficiency virus, gonorrhoea rates, and changed sexual behaviour in homosexual men in London. Lancet (1987) 7.71
Sexual behaviour in Britain: early heterosexual experience. Lancet (2001) 7.62
Apolipoproteins and ischaemic heart disease: implications for screening. Lancet (1994) 6.62
Measuring sexual behaviour: methodological challenges in survey research. Sex Transm Infect (2001) 6.21
Chloroplast transformation in Chlamydomonas with high velocity microprojectiles. Science (1988) 5.91
Comparison of two methods of screening for genital chlamydial infection in women attending in general practice: cross sectional survey. BMJ (1997) 5.29
Increase in high risk sexual behaviour among homosexual men, London 1996-8: cross sectional, questionnaire study. BMJ (2000) 4.51
Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J Virol (1987) 4.49
Distinctive nucleotide sequences adjacent to multiple initiation and termination sites of an early vaccinia virus gene. Cell (1981) 4.42
Human C'3: evidence for the liver as the primary site of synthesis. Science (1969) 4.17
From exceptionalism to normalisation: a reappraisal of attitudes and practice around HIV testing. BMJ (1998) 4.09
Pupil-led sex education in England (RIPPLE study): cluster-randomised intervention trial. Lancet (2004) 3.86
Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ (1994) 3.71
Direct mapping of adeno-associated virus capsid proteins B and C: a possible ACG initiation codon. Proc Natl Acad Sci U S A (1985) 3.31
Controlling genital chlamydial infection. BMJ (1996) 3.29
Sexual lifestyles under scrutiny. Nature (1990) 3.19
Molecular cloning and characterization of hepatitis A virus cDNA. Proc Natl Acad Sci U S A (1983) 2.92
Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int (1992) 2.89
Incompletely base-paired flip-flop terminal loops link the two DNA strands of the vaccinia virus genome into one uninterrupted polynucleotide chain. Cell (1982) 2.76
Risk behaviours for HIV infection among injecting drug users attending a drug dependency clinic. BMJ (1989) 2.68
Purification and characterization of a DNA-dependent RNA polymerase from vaccinia virions. J Biol Chem (1980) 2.66
Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group. JAMA (1994) 2.56
The acquired immune deficiency syndrome and epidemic of infection with human immunodeficiency virus: costs of care and prevention in an inner London district. Br Med J (Clin Res Ed) (1986) 2.54
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 2.49
Active surveillance of sexual behaviour among homosexual men in London. Commun Dis Public Health (1998) 2.45
Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli. J Virol (1999) 2.37
Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med (1992) 2.34
A cognitive behavioural intervention to reduce sexually transmitted infections among gay men: randomised trial. BMJ (2001) 2.30
Provision of sex education and early sexual experience: the relation examined. BMJ (1995) 2.21
Attitudes to tracing and notifying contacts of people with HIV infection. BMJ (1992) 2.19
A preliminary study of the transmission dynamics of the human immunodeficiency virus (HIV), the causative agent of AIDS. IMA J Math Appl Med Biol (1986) 2.18
Preliminary report: accurate assays for anti-HIV in urine. Lancet (1990) 2.17
Cardiac surgery in Wessex: review of 1000 consecutive open-heart procedures. Br Med J (1976) 2.16
AIDS across Europe, 1994-98: the EuroSIDA study. Lancet (2000) 2.13
Progression of autosomal-dominant polycystic kidney disease in children. Kidney Int (2001) 2.09
Maintaining patient access to GUM clinics: is it compatible with appointments? Sex Transm Infect (2003) 2.08
Increasing risk behaviour and high levels of undiagnosed HIV infection in a community sample of homosexual men. Sex Transm Infect (2004) 2.06
Surveillance of sexual behaviour among homosexual men in a central London health authority. Genitourin Med (1997) 2.03
Methodology of the National Survey of Sexual Attitudes and Lifestyles. J R Stat Soc Ser A Stat Soc (1993) 1.95
Who reports sexual function problems? Empirical evidence from Britain's 2000 National Survey of Sexual Attitudes and Lifestyles. Sex Transm Infect (2005) 1.95
Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA. Br J Pharmacol (1976) 1.95
Transformation of chloroplast ribosomal RNA genes in Chlamydomonas: molecular and genetic characterization of integration events. Genetics (1990) 1.93
Immunofixation electrophoresis: a technique for the study of protein polymorphism. Vox Sang (1969) 1.88
Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis (2000) 1.86
Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1995) 1.81
Behavioural intervention trials for HIV/STD prevention in schools: are they feasible? Sex Transm Infect (1998) 1.78
Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J Virol (1995) 1.77
Intraoperative left ventricular perforation with false aneurysm formation. Br Heart J (1976) 1.75
Trends in HIV testing and recording of HIV status in the UK primary care setting: a retrospective cohort study 1995-2005. Sex Transm Infect (2009) 1.74
Genetic diversity and distribution of Peromyscus-borne hantaviruses in North America. Emerg Infect Dis (1999) 1.74
An evaluation of partner notification for HIV infection in genitourinary medicine clinics in England. AIDS (1998) 1.71
Voluntary universal antenatal HIV testing. Br J Obstet Gynaecol (1996) 1.71
The role and effectiveness of partner notification in STD control: a review. Genitourin Med (1996) 1.68
The accuracy of reported sensitive sexual behaviour in Britain: exploring the extent of change 1990-2000. Sex Transm Infect (2002) 1.67
Report of Nomenclature Meeting for alpha 1-antitrypsin, INSERM, Rouen/Bois-Guillaume-1978. Hum Genet (1980) 1.66
Implications for HIV testing policy derived from combining data on voluntary confidential testing with viral sequences and serological analyses. Sex Transm Infect (2008) 1.66
A school-based randomized controlled trial of peer-led sex education in England. Control Clin Trials (2003) 1.65
Road safety in drivers with Parkinson disease. Neurology (2009) 1.65
Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet (1995) 1.62
Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1994) 1.61
Why the(y) wait? Key informant understandings of factors contributing to late presentation and poor utilization of HIV health and social care services by African migrants in Britain. AIDS Care (2007) 1.59
Long-term follow-up of upper extremity implanted venous access devices in oncology patients. J Vasc Interv Radiol (1999) 1.56
Increased frequency of heterozygotes for alpha1 antitrypsin variants in individuals with either sex chromosome mosaicism or trisomy 21. Nature (1976) 1.56
Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis (2000) 1.50
Private sexual behavior, public opinion, and public health policy related to sexually transmitted diseases: a US-British comparison. Am J Public Health (1998) 1.49
Assessing participation bias in a sexual behaviour survey: implications for measuring HIV risk. AIDS (1997) 1.49
Disease progression and survival in HIV-1-infected Africans in London. AIDS (1998) 1.47
Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES folding. J Virol (2000) 1.47
Gastrotracheal fistula: a late complication after transhiatal esophagectomy. Ann Thorac Surg (1989) 1.46
Cytokines, nitric oxide, heat shock proteins and virulence in Toxoplasma. Parasitol Today (1999) 1.45
Treating sexually transmitted infections in primary care: a missed opportunity? Sex Transm Infect (2003) 1.45
Bronchopulmonary foregut malformations. The spectrum of anomalies. Ann Surg (1986) 1.44
Experimentally induced Bartonella henselae infections followed by challenge exposure and antimicrobial therapy in cats. Am J Vet Res (1996) 1.44
Spectrum of disease in Africans with AIDS in London. AIDS (1996) 1.43
Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study Group. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.43
Inheritance of human alpha-1-acid glycoprotein (orosomucoid) variants. J Clin Invest (1969) 1.43
Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study Group. BMJ (1994) 1.41
Echocardiographic findings in autosomal dominant polycystic kidney disease. N Engl J Med (1988) 1.40
Evaluation of needle exchange in central London: behaviour change and anti-HIV status over one year. AIDS (1989) 1.39
Monoclonal antibodies to Toxoplasma cell membrane surface antigens protect mice from toxoplasmosis. J Protozool (1983) 1.39
HIV, sexually transmitted infections, and risk behaviours in male commercial sex workers in Sydney. Sex Transm Infect (2000) 1.37
Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1997) 1.37
Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology (1990) 1.36
Relationship between antibodies to herpes simplex virus (HSV) and symptoms of HSV infection. J Infect Dis (1996) 1.36
A new look at the neonatal electrocardiogram. Br Med J (1976) 1.36
Renal structure and hypertension in autosomal dominant polycystic kidney disease. Kidney Int (1990) 1.36
Structure and replication of vaccinia virus telomeres. Cold Spring Harb Symp Quant Biol (1983) 1.36
Genetic typing of alpha1-antitrypsin by immunofixation electrophoresis, identification of subtypes of Pi M. J Lab Clin Med (1976) 1.36
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival. J Acquir Immune Defic Syndr (1999) 1.35
Study of cardiac arrhythmias and other forms of conduction abnormality in newborn infants. Br Med J (1977) 1.35
Detection of Campylobacter pylori DNA by hybridisation with non-radioactive probes in comparison with a 32P-labelled probe. J Med Microbiol (1988) 1.33
Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease. Am J Kidney Dis (1992) 1.33
A human monoclonal antibody that recognizes viral polypeptides and in vitro translation products of the genome of the hepatitis D virus. J Infect Dis (1987) 1.32
Sequence analysis of hepatitis A virus cDNA coding for capsid proteins and RNA polymerase. Proc Natl Acad Sci U S A (1985) 1.32
Retrospective serological and genetic study of the distribution of hantaviruses in Greece. J Med Virol (1998) 1.31
Recognition of recombinant Toxoplasma gondii antigens by human sera in an ELISA. Parasitol Res (1991) 1.31
An ultraviolet-sensitive RNA structural element in a viroid-like domain of the hepatitis delta virus. Science (1989) 1.31